Cargando…
Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
The BCL6 oncogene plays a crucial role in sustaining diffuse large B-cell lymphomas (DLBCL) through transcriptional repression of key checkpoint genes. BCL6-targeted therapy kills lymphoma cells by releasing these checkpoints. However BCL6 also directly represses several DLBCL oncogenes such as BCL2...
Autores principales: | Dupont, Thibault, Yang, ShaoNing, Patel, Jayeshkumar, Hatzi, Katerina, Malik, Alka, Tam, Wayne, Martin, Peter, Leonard, John, Melnick, Ari, Cerchietti, Leandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823124/ https://www.ncbi.nlm.nih.gov/pubmed/26657288 http://dx.doi.org/10.18632/oncotarget.6513 |
Ejemplares similares
-
A purine scaffold Hsp90 inhibitor destabilizes Bcl6 and has specific anti-tumor activity in Bcl6 dependent B-cell lymphomas
por: Cerchietti, Leandro C, et al.
Publicado: (2009) -
The transcriptional modulator BCL6 as a molecular target for breast cancer therapy
por: Walker, Sarah R., et al.
Publicado: (2014) -
Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated through distinct biochemical mechanisms
por: Huang, Chuanxin, et al.
Publicado: (2013) -
BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms
por: Hatzi, Katerina, et al.
Publicado: (2015) -
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
por: Hurtz, Christian, et al.
Publicado: (2011)